Evidence map›Paper›PMID 33561239›Full record

ArticleG3 (Bethesda, Md.)2021

FlyORF-TaDa allows rapid generation of new lines for in vivo cell-type-specific profiling of protein-DNA interactions in Drosophila melanogaster.

Gabriel N Aughey, Caroline Delandre, John P D McMullen, Tony D Southall, Owen J Marshall

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriel N AugheyImperial College London, Sir Ernst Chain Building, South Kensington Campus, London SW7 2AZ, UK.
Caroline DelandreMenzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart 7000, Australia.
John P D McMullenMenzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart 7000, Australia.
Tony D SouthallImperial College London, Sir Ernst Chain Building, South Kensington Campus, London SW7 2AZ, UK.
Owen J MarshallMenzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart 7000, Australia.

Funding

Biotechnology and Biological Sciences Research Council BBP0179241Wellcome Trust
6 · The paper itself

Abstract

Targeted DamID (TaDa) is an increasingly popular method of generating cell-type-specific DNA-binding profiles in vivo. Although sensitive and versatile, TaDa requires the generation of new transgenic fly lines for every protein that is profiled, which is both time-consuming and costly. Here, we describe the FlyORF-TaDa system for converting an existing FlyORF library of inducible open reading frames (ORFs) to TaDa lines via a genetic cross, with recombinant progeny easily identifiable by eye color. Profiling the binding of the H3K36me3-associated chromatin protein MRG15 in larval neural stem cells using both FlyORF-TaDa and conventional TaDa demonstrates that new lines generated using this system provide accurate and highly reproducible DamID-binding profiles. Our data further show that MRG15 binds to a subset of active chromatin domains in vivo. Courtesy of the large coverage of the FlyORF library, the FlyORF-TaDa system enables the easy creation of TaDa lines for 74% of all transcription factors and chromatin-modifying proteins within the Drosophila genome.

Indexed as

Drosophila melanogasterDrosophila ProteinsAnimalsChromatinChromosomal Proteins, Non-HistoneDNADNA MethylationProtein BindingChromatinChromosomal Proteins, Non-HistoneDNADrosophila ProteinsMRG15 protein, DrosophilaChromatinDamIDDevelopmentNeural stem cellsTranscriptionTranscription factor

Identifiers

PMID33561239
PMCPMC8022459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.